ampelopsin has been researched along with Degenerative Diseases, Central Nervous System in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JG; Chen, LL; Li, JE; Sun, CC; Wang, WJ; Yin, ZP; Zhang, QF; Zheng, GD | 1 |
| Copeland, RL; Csoka, AB; Getachew, B; Manaye, KF; Tizabi, Y | 1 |
| Chen, S; Jia, Y; Lei, W; Li, K; Li, Y; Liu, B; Liu, Z; Ma, Y; Mu, S; OuYang, L; Wang, W; Wu, J; Zhan, M; Zhu, Y | 1 |
3 other study(ies) available for ampelopsin and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Dihydromyricetin Improves Cognitive Impairments in d-Galactose-Induced Aging Mice through Regulating Oxidative Stress and Inhibition of Acetylcholinesterase.
Topics: Acetylcholinesterase; Aging; Animals; Cognitive Dysfunction; Flavonols; Galactose; Mice; Neurodegenerative Diseases; Oxidative Stress | 2022 |
Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease.
Topics: Cell Line, Tumor; Dopamine; Dopaminergic Neurons; gamma-Aminobutyric Acid; Humans; Neuroblastoma; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease | 2023 |
Dihydromyricetin Ameliorates 3NP-induced Behavioral Deficits and Striatal Injury in Rats.
Topics: Animals; Apoptosis; Corpus Striatum; Flavonols; Locomotion; Male; Malondialdehyde; Maze Learning; Neurodegenerative Diseases; Neuroprotective Agents; Nitro Compounds; Oxidative Stress; Positron Emission Tomography Computed Tomography; Propionates; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2016 |